Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The global Humira market is projected to grow from US$ 15530 million in 2024 to US$ 9235.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of -8.3% during the forecast period.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn鈥檚 disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
麻豆原创 competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
Report Covers:
This report presents an overview of global market for Humira, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Humira, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Humira, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Humira sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Humira market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Humira sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Cadila Healthcare
Amgen
Boehringer Ingelheim
Samsung Bioepis
Biocon
Fresenius Kabi
Celltrion
Coherus
Sandoz
Torrent Pharmaceuticals
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn鈥檚 Disease
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Humira in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Humira manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Humira sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Humira Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Humira 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Humira Syringe
1.2.3 Humira Pen
1.3 麻豆原创 by Application
1.3.1 Global Humira 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Ankylosing Spondylitis
1.3.3 Rheumatoid Arthritis
1.3.4 Crohn鈥檚 Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Humira Sales Estimates and Forecasts 2019-2030
2.2 Global Humira Revenue by Region
2.2.1 Global Humira Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Humira Revenue by Region (2019-2024)
2.2.3 Global Humira Revenue by Region (2025-2030)
2.2.4 Global Humira Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Humira Sales Estimates and Forecasts 2019-2030
2.4 Global Humira Sales by Region
2.4.1 Global Humira Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Humira Sales by Region (2019-2024)
2.4.3 Global Humira Sales by Region (2025-2030)
2.4.4 Global Humira Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Humira Sales by Manufacturers
3.1.1 Global Humira Sales by Manufacturers (2019-2024)
3.1.2 Global Humira Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Humira in 2023
3.2 Global Humira Revenue by Manufacturers
3.2.1 Global Humira Revenue by Manufacturers (2019-2024)
3.2.2 Global Humira Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Humira Revenue in 2023
3.3 Global Key Players of Humira, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Humira Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Humira 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Humira, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Humira, Product Offered and Application
3.8 Global Key Manufacturers of Humira, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Humira Sales by Type
4.1.1 Global Humira Historical Sales by Type (2019-2024)
4.1.2 Global Humira Forecasted Sales by Type (2025-2030)
4.1.3 Global Humira Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Humira Revenue by Type
4.2.1 Global Humira Historical Revenue by Type (2019-2024)
4.2.2 Global Humira Forecasted Revenue by Type (2025-2030)
4.2.3 Global Humira Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Humira Price by Type
4.3.1 Global Humira Price by Type (2019-2024)
4.3.2 Global Humira Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Humira Sales by Application
5.1.1 Global Humira Historical Sales by Application (2019-2024)
5.1.2 Global Humira Forecasted Sales by Application (2025-2030)
5.1.3 Global Humira Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Humira Revenue by Application
5.2.1 Global Humira Historical Revenue by Application (2019-2024)
5.2.2 Global Humira Forecasted Revenue by Application (2025-2030)
5.2.3 Global Humira Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Humira Price by Application
5.3.1 Global Humira Price by Application (2019-2024)
5.3.2 Global Humira Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Humira 麻豆原创 Size by Type
6.1.1 US & Canada Humira Sales by Type (2019-2030)
6.1.2 US & Canada Humira Revenue by Type (2019-2030)
6.2 US & Canada Humira 麻豆原创 Size by Application
6.2.1 US & Canada Humira Sales by Application (2019-2030)
6.2.2 US & Canada Humira Revenue by Application (2019-2030)
6.3 US & Canada Humira 麻豆原创 Size by Country
6.3.1 US & Canada Humira Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Humira Sales by Country (2019-2030)
6.3.3 US & Canada Humira Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Humira 麻豆原创 Size by Type
7.1.1 Europe Humira Sales by Type (2019-2030)
7.1.2 Europe Humira Revenue by Type (2019-2030)
7.2 Europe Humira 麻豆原创 Size by Application
7.2.1 Europe Humira Sales by Application (2019-2030)
7.2.2 Europe Humira Revenue by Application (2019-2030)
7.3 Europe Humira 麻豆原创 Size by Country
7.3.1 Europe Humira Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Humira Sales by Country (2019-2030)
7.3.3 Europe Humira Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Humira 麻豆原创 Size
8.1.1 China Humira Sales (2019-2030)
8.1.2 China Humira Revenue (2019-2030)
8.2 China Humira 麻豆原创 Size by Application
8.2.1 China Humira Sales by Application (2019-2030)
8.2.2 China Humira Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Humira 麻豆原创 Size by Type
9.1.1 Asia Humira Sales by Type (2019-2030)
9.1.2 Asia Humira Revenue by Type (2019-2030)
9.2 Asia Humira 麻豆原创 Size by Application
9.2.1 Asia Humira Sales by Application (2019-2030)
9.2.2 Asia Humira Revenue by Application (2019-2030)
9.3 Asia Humira Sales by Region
9.3.1 Asia Humira Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Humira Revenue by Region (2019-2030)
9.3.3 Asia Humira Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Humira 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Humira Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Humira Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Humira 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Humira Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Humira Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Humira Sales by Country
10.3.1 Middle East, Africa and Latin America Humira Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Humira Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Humira Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AbbVie Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Overview
11.2.3 Eisai Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Eisai Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eisai Recent Developments
11.3 Cadila Healthcare
11.3.1 Cadila Healthcare Company Information
11.3.2 Cadila Healthcare Overview
11.3.3 Cadila Healthcare Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Cadila Healthcare Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cadila Healthcare Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Amgen Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Overview
11.5.3 Boehringer Ingelheim Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Boehringer Ingelheim Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Samsung Bioepis
11.6.1 Samsung Bioepis Company Information
11.6.2 Samsung Bioepis Overview
11.6.3 Samsung Bioepis Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Samsung Bioepis Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Samsung Bioepis Recent Developments
11.7 Biocon
11.7.1 Biocon Company Information
11.7.2 Biocon Overview
11.7.3 Biocon Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Biocon Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Recent Developments
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Information
11.8.2 Fresenius Kabi Overview
11.8.3 Fresenius Kabi Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Fresenius Kabi Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fresenius Kabi Recent Developments
11.9 Celltrion
11.9.1 Celltrion Company Information
11.9.2 Celltrion Overview
11.9.3 Celltrion Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Celltrion Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Celltrion Recent Developments
11.10 Coherus
11.10.1 Coherus Company Information
11.10.2 Coherus Overview
11.10.3 Coherus Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Coherus Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Coherus Recent Developments
11.11 Sandoz
11.11.1 Sandoz Company Information
11.11.2 Sandoz Overview
11.11.3 Sandoz Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Sandoz Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sandoz Recent Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Information
11.12.2 Torrent Pharmaceuticals Overview
11.12.3 Torrent Pharmaceuticals Humira Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Torrent Pharmaceuticals Humira Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Torrent Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Humira Industry Chain Analysis
12.2 Humira Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Humira Production Mode & Process
12.4 Humira Sales and 麻豆原创ing
12.4.1 Humira Sales Channels
12.4.2 Humira Distributors
12.5 Humira Customers
13 麻豆原创 Dynamics
13.1 Humira Industry Trends
13.2 Humira 麻豆原创 Drivers
13.3 Humira 麻豆原创 Challenges
13.4 Humira 麻豆原创 Restraints
14 Key Findings in The Global Humira Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
AbbVie
Eisai
Cadila Healthcare
Amgen
Boehringer Ingelheim
Samsung Bioepis
Biocon
Fresenius Kabi
Celltrion
Coherus
Sandoz
Torrent Pharmaceuticals
听
听
*If Applicable.